BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26063974)

  • 1. Notch Signaling Pathway Was Involved in Regulating Programmed Cell Death 1 Expression during Sepsis-Induced Immunosuppression.
    Pan T; Liu Z; Yin J; Zhou T; Liu J; Qu H
    Mediators Inflamm; 2015; 2015():539841. PubMed ID: 26063974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study.
    Shao R; Fang Y; Yu H; Zhao L; Jiang Z; Li CS
    Crit Care; 2016 May; 20(1):124. PubMed ID: 27156867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients.
    Zhang Y; Li J; Lou J; Zhou Y; Bo L; Zhu J; Zhu K; Wan X; Cai Z; Deng X
    Crit Care; 2011; 15(1):R70. PubMed ID: 21349174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of programmed cell death 1 ligand 1 on neutrophils may be involved in sepsis-induced immunosuppression: an animal study and a prospective case-control study.
    Wang JF; Li JB; Zhao YJ; Yi WJ; Bian JJ; Wan XJ; Zhu KM; Deng XM
    Anesthesiology; 2015 Apr; 122(4):852-63. PubMed ID: 25437496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis.
    Liu Q; Li CS
    Chin Med J (Engl); 2017 Apr; 130(8):986-992. PubMed ID: 28397730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway.
    Zhang SA; Niyazi HE; Hong W; Tuluwengjiang GL; Zhang L; Zhang Y; Su WP; Bao YX
    Tumour Biol; 2017 Mar; 39(3):1010428317692237. PubMed ID: 28351328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine activation of canonical BMP signaling regulates PD-L1 and PD-L2 expression in human dendritic cells.
    Martínez VG; Hidalgo L; Valencia J; Hernández-López C; Entrena A; del Amo BG; Zapata AG; Vicente A; Sacedón R; Varas A
    Eur J Immunol; 2014 Apr; 44(4):1031-8. PubMed ID: 24532425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signaling pathway regulates T cell dysfunction in septic patients.
    Jin B; Liang Y; Liu Y; Zhang LX; Xi FY; Wu WJ; Li Y; Liu GH
    Int Immunopharmacol; 2019 Nov; 76():105907. PubMed ID: 31525636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
    Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
    Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1/PD-Ls pathways between CD4(+) T cells and pleural mesothelial cells in human tuberculous pleurisy.
    Yin W; Tong ZH; Cui A; Zhang JC; Ye ZJ; Yuan ML; Zhou Q; Shi HZ
    Tuberculosis (Edinb); 2014 Mar; 94(2):131-9. PubMed ID: 24406080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment.
    Krönig H; Kremmler L; Haller B; Englert C; Peschel C; Andreesen R; Blank CU
    Eur J Haematol; 2014 Mar; 92(3):195-203. PubMed ID: 24175978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the PD-1 and PD-L1 expressions of splenic dendritic cells in multiple-organ dysfunction syndrome mice and their significance.
    Liu Q; Lu JY; Wang XH; Qu BJ; Li SR; Kang JR
    Genet Mol Res; 2014 Sep; 13(3):7666-72. PubMed ID: 25299080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Takizawa S; Kaneyama T; Tsugane S; Takeichi N; Yanagisawa S; Ichikawa M; Yagita H; Kim BS; Koh CS
    J Neuroimmunol; 2014 Sep; 274(1-2):78-85. PubMed ID: 25027060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
    Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN
    Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte Programmed Death Ligand-1, A Predicator for 28-Day Mortality in Septic Patients.
    Tai H; Xing H; Xiang D; Zhu Z; Mei H; Sun W; Zhang W
    Am J Med Sci; 2018 Apr; 355(4):362-367. PubMed ID: 29661350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased PD-1 on CD4(+)CD28(-) T cell and soluble PD-1 ligand-1 in patients with T2DM: association with atherosclerotic macrovascular diseases.
    Shi B; Du X; Wang Q; Chen Y; Zhang X
    Metabolism; 2013 Jun; 62(6):778-85. PubMed ID: 23398844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
    Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
    Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.
    Prosser ME; Brown CE; Shami AF; Forman SJ; Jensen MC
    Mol Immunol; 2012 Jul; 51(3-4):263-72. PubMed ID: 22503210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of PD-L1 on immunosuppression of bacterial sepsis and its relevant mechanism].
    Wang F; Yang MY; Wang B; Qu ZL; Hu QR
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):606-610. PubMed ID: 34821092
    [No Abstract]   [Full Text] [Related]  

  • 20. Nuclear factor-κB/p65 responds to changes in the Notch signaling pathway in murine BV-2 cells and in amoeboid microglia in postnatal rats treated with the γ-secretase complex blocker DAPT.
    Cao Q; Li P; Lu J; Dheen ST; Kaur C; Ling EA
    J Neurosci Res; 2010 Sep; 88(12):2701-14. PubMed ID: 20648656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.